Alexandria Real Estate Equities, Inc.
ARE · NYSE
Company research
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is an S&P 500 urban office REIT and the pioneering, longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems uniquely focused on the life science, agtech, and technology sectors since its founding in 1994. Headquartered in Pasadena, California, the company strategically develops and operates Class A/A+ properties in AAA innovation cluster locations across key markets including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. As of September 30, 2024, Alexandria reported a total market capitalization of approximately $33.1 billion and an asset base encompassing 41.8 million RSF of operating properties, along with 5.3 million RSF of properties under construction, underpinning its dominant position in life science real estate infrastructure. The company further supports its tenant ecosystem through Alexandria Venture Investments, a dedicated venture capital platform providing strategic capital to transformative life science and technology companies, reinforcing its mission-driven approach to building the future of the life science industry.
Research reports
This report applies a discounted cash flow model and price-to-sales analysis to estimate ARE’s intrinsic value at roughly 78–79 per share versus a then-current price around the high-40s, concluding the stock is significantly undervalued with a substantial margin of safety. It discusses how rising interest rates and changing demand for life-science office and lab space pressure REITs, weighs these risks against the quality of ARE’s innovation-cluster assets, and ultimately frames the shares as an undervalued long-term opportunity rather than a value trap.
Yahoo Finance · November 24, 2025Does Alexandria Real Estate Equities Present Opportunity After 51% Drop Amid REIT Downturn?This analysis examines whether ARE’s roughly 51% share price decline amid a broader REIT downturn represents a recovery opportunity or a value trap, emphasizing the importance of rigorous valuation work in the current environment. It focuses on sector-wide headwinds facing office and lab-space REITs and questions whether ARE’s asset portfolio and fundamentals can justify a rebound from depressed levels, highlighting uncertainty around how macro and industry pressures will resolve.